돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 152생성일: 2026년 10월 23일

2,4-Dichloropyridine → 4-chloro-N-(2-methylpyrazol-3-yl)pyridin-2-amine

https://huagongshe.com/ko/reaction/152

반응식

참여 물질

역할이름HCID투입량
반응물2,4-DichloropyridineHCID 33515—
반응물2-Methyl-2H-pyrazol-3-ylamineHCID 136927—
시약Sodium t-butoxideHCID 23676156—
촉매1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
촉매Bis(dibenzylideneacetone)palladiumHCID 9811564—
용매1,4-DioxaneHCID 31275—
생성물4-chloro-N-(2-methylpyrazol-3-yl)pyridin-2-amineHCID 12143971356.88%

반응 조건

온도130 °C

반응 단계

TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (251 mg, 0.27 mmol) was added in one portion to 2,4-dichloropyridine (1000mg, 6.76 mmol), 1,3-dimethyl-1H-pyrazol-5-amine (826 mg, 7.43 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (461 mg, 0.80 mmol) and sodium tert-butoxide (974 mg, 10.14 mmol) in 1,4-dioxane (60 mL) warmed to 130ºC over a period of 10 minutes under nitrogen. The resulting mixture was stirred at 130°C for 20 hours. The reaction mixture was evaporated to dryness and redissolved in DCM (150 mL). Solids were filtered off by suction and the filtrate subsequently washed with water (100 mL). The organic layer was dried over MgSO4, filtered and evaporated to afford crude product. The crude product was purified by flash silica chromatography, elution gradient 0 to 4% MeOH in DCM. Pure fractions were evaporated to dryness to afford 4-chloro-N-(1-methyl-1H-pyrazol-5-yl)pyridin-2-amine (802 mg, 56.9 %) as a yellow oil which crystallised on standing.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-3c8e64b916074a0fa79f8b674402d3e9
출처 메모750 AstraZeneca ELN dataset